UNITED THERAPEUTICS CORP (UTHR) Stock Analyst Earnings Estimates
NASDAQ:UTHR - Nasdaq - US91307C1027 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.686B 13.63% | 1.936B 14.88% | 2.328B 20.20% | 2.932B 25.97% | 3.238B 10.44% | 3.449B 6.52% | 3.729B 8.12% | 3.995B 7.13% | 4.304B 7.73% | 4.647B 7.97% | 4.331B -6.80% | 4.679B 8.04% | |
| EBITDA YoY % growth | 738.4M 14.75% | 1.042B 41.14% | 1.242B 19.14% | 1.529B 23.14% | 1.696B 10.92% | 1.716B 1.18% | 1.466B -14.57% | 1.265B -13.71% | 1.131B -10.59% | 1.079B -4.60% | 1.044B -3.24% | N/A | |
| EBIT YoY % growth | 688.5M 15.99% | 990.9M 43.92% | 1.189B 19.94% | 1.431B 20.40% | 1.663B 16.21% | 1.72B 3.43% | 1.893B 10.06% | 2.177B 15.00% | 2.347B 7.81% | 2.616B 11.46% | 2.159B -17.47% | 2.328B 7.83% | |
| Operating Margin | 40.85% | 51.17% | 51.06% | 48.81% | 51.36% | 49.87% | 50.76% | 54.49% | 54.53% | 56.29% | 49.85% | 49.75% | |
| EPS YoY % growth | 10.03 -13.39% | 15.02 49.75% | 19.84 32.09% | 25.37 27.89% | 28.25 11.33% | 29.80 5.50% | 32.07 7.60% | 54.17 68.94% | 60.85 12.33% | 72.13 18.54% | 16.02 -77.79% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.44 47.62% | 6.90 11.82% | 7.37 26.01% | 7.59 18.71% | 7.58 17.81% | 6.36 -7.75% | 6.66 -9.65% | 7.20 -5.07% | 6.90 -9.07% |
| Revenue Q2Q % growth | 749.44M 21.92% | 769.18M 13.50% | 811.08M 13.45% | 843.12M 12.58% | 848.41M 13.21% | 822.77M 6.97% | 857.64M 5.74% | 918.65M 8.96% | 883.64M 4.15% |
| EBITDA Q2Q % growth | 401.15M 26.59% | 396.99M 6.92% | 418.88M 18.46% | 431.35M -6.43% | 421.7M 5.12% | 418.79M 5.49% | 436.54M 4.22% | 467.6M 8.40% | 449.77M 6.66% |
| EBIT Q2Q % growth | 375.66M 42.46% | 409.19M 14.84% | 430.04M 34.43% | 452.95M 10.96% | 457.15M 21.69% | 418.79M 2.35% | 436.54M 1.51% | 467.6M 3.23% | 449.77M -1.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.39 18.77% | 6.55 | -0.16 | -2.49% |
| Q2 2024 Q2Q % growth | 5.85 11.64% | 6.53 | -0.68 | -10.35% |
| Q1 2024 Q2Q % growth | 6.17 26.95% | 5.76 | 0.41 | 7.04% |
| Q4 2023 Q2Q % growth | 4.36 63.30% | 4.27 | 0.09 | 2.12% |
| Q3 2023 Q2Q % growth | 5.38 9.57% | 5.14 | 0.24 | 4.59% |
| Q2 2023 Q2Q % growth | 5.24 117.43% | 4.60 | 0.64 | 14.02% |
| Q1 2023 Q2Q % growth | 4.86 -3.38% | 4.62 | 0.24 | 5.31% |
| Q4 2022 Q2Q % growth | 2.67 13.62% | 4.60 | -1.93 | -41.99% |
| Q3 2022 Q2Q % growth | 4.91 43.57% | 3.97 | 0.94 | 23.61% |
| Q2 2022 Q2Q % growth | 2.41 -33.97% | 4.22 | -1.81 | -42.84% |
| Q1 2022 Q2Q % growth | 5.03 724.59% | 3.41 | 1.62 | 47.41% |
| Q4 2021 Q2Q % growth | 2.35 7.31% | 3.79 | -1.44 | -38.00% |
| Q3 2021 Q2Q % growth | 3.42 -11.40% | 3.66 | -0.24 | -6.66% |
| Q2 2021 Q2Q % growth | 3.65 51.45% | 3.08 | 0.57 | 18.49% |
| Q1 2021 Q2Q % growth | 0.61 -80.45% | 3.00 | -2.39 | -79.67% |
| Q4 2020 Q2Q % growth | 2.19 82.50% | 3.20 | -1.01 | -31.60% |
| Q3 2020 Q2Q % growth | 3.86 22.15% | 2.89 | 0.97 | 33.66% |
| Q2 2020 Q2Q % growth | 2.41 -41.36% | 2.93 | -0.52 | -17.70% |
| Q1 2020 Q2Q % growth | 3.12 11.03% | 2.80 | 0.32 | 11.23% |
| Q4 2019 Q2Q % growth | 1.20 | 2.73 | -1.53 | -56.12% |
| Q3 2019 Q2Q % growth | 3.16 | 2.49 | 0.67 | 26.97% |
| Q2 2019 Q2Q % growth | 4.11 | 2.54 | 1.57 | 61.68% |
| Q1 2019 Q2Q % growth | 2.81 | 2.83 | -0.02 | -0.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 748.9M 22.89% | 737.03M | 11.87M | 1.61% |
| Q2 2024 Q2Q % growth | 714.9M 19.85% | 705.7M | 9.2M | 1.30% |
| Q1 2024 Q2Q % growth | 677.7M 33.70% | 636.44M | 41.26M | 6.48% |
| Q4 2023 Q2Q % growth | 614.7M 25.07% | 587.39M | 27.31M | 4.65% |
| Q3 2023 Q2Q % growth | 609.4M 18.10% | 598.84M | 10.56M | 1.76% |
| Q2 2023 Q2Q % growth | 596.5M 27.76% | 534.65M | 61.85M | 11.57% |
| Q1 2023 Q2Q % growth | 506.9M 9.74% | 524.66M | -17.76M | -3.39% |
| Q4 2022 Q2Q % growth | 491.5M 18.38% | 529.59M | -38.09M | -7.19% |
| Q3 2022 Q2Q % growth | 516M 16.03% | 503.07M | 12.93M | 2.57% |
| Q2 2022 Q2Q % growth | 466.9M 4.57% | 470.28M | -3.38M | -0.72% |
| Q1 2022 Q2Q % growth | 461.9M 21.84% | 428.42M | 33.48M | 7.81% |
| Q4 2021 Q2Q % growth | 415.2M 7.87% | 436.17M | -20.97M | -4.81% |
| Q3 2021 Q2Q % growth | 444.7M 17.00% | 429.88M | 14.82M | 3.45% |
| Q2 2021 Q2Q % growth | 446.5M 23.34% | 386.11M | 60.39M | 15.64% |
| Q1 2021 Q2Q % growth | 379.1M 6.40% | 376.33M | 2.77M | 0.74% |
| Q4 2020 Q2Q % growth | 384.9M 23.72% | 369.28M | 15.62M | 4.23% |
| Q3 2020 Q2Q % growth | 380.1M -5.33% | 365.63M | 14.47M | 3.96% |
| Q2 2020 Q2Q % growth | 362M -3.10% | 346.77M | 15.23M | 4.39% |
| Q1 2020 Q2Q % growth | 356.3M -1.74% | 351.21M | 5.09M | 1.45% |
| Q4 2019 Q2Q % growth | 311.1M | 364.92M | -53.82M | -14.75% |
| Q3 2019 Q2Q % growth | 401.5M | 344.36M | 57.14M | 16.59% |
| Q2 2019 Q2Q % growth | 373.6M | 338.79M | 34.81M | 10.27% |
| Q1 2019 Q2Q % growth | 362.6M | 342.14M | 20.46M | 5.98% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.56% | -3.56% | 1.56% | 1.53% |
| Revenue | -0.7% | -0.7% | -0.07% | -0.17% |